These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 951337)
41. [Behavior problems in phenylketonuria. Attempt at a biochemical interpretation based on a personal case and a review of the literature]. Dalery J; Maillet J; de Villard R Encephale; 1983; 9(3):279-90. PubMed ID: 6653487 [TBL] [Abstract][Full Text] [Related]
42. [Investigations on the behaviour of tryptophan in children with phenylketonuria (author's transl)]. Bozkowa K; Duczyńska N; Cabalska B Probl Med Wieku Rozwoj; 1973; 3():21-9. PubMed ID: 4805441 [No Abstract] [Full Text] [Related]
43. [Optimization of metabolic adjustment in phenylketonuria]. Theile H; Burkhardt GO; Bührdel P Padiatr Grenzgeb; 1977; 16(2):69-76. PubMed ID: 865853 [No Abstract] [Full Text] [Related]
44. [The effect of diet on several metabolic indices in phenylketonuria]. Bulakhova LA; Chernitskaia II; Usherenko LS Tsitol Genet; 1974; 8(1):31-3. PubMed ID: 4364293 [No Abstract] [Full Text] [Related]
45. Biochemical factors in mental retardation. Hsia DY Proc Annu Meet Am Psychopathol Assoc; 1967; 56():28-44. PubMed ID: 4966303 [No Abstract] [Full Text] [Related]
46. Comments on in vivo proton magnetic resonance spectroscopy in phenylketonuria. Kreis R Eur J Pediatr; 2000 Oct; 159 Suppl 2():S126-8. PubMed ID: 11221741 [No Abstract] [Full Text] [Related]
47. Significant phenylalanine hydroxylation in vivo in patients with classical phenylketonuria. Thompson GN; Halliday D J Clin Invest; 1990 Jul; 86(1):317-22. PubMed ID: 2365821 [TBL] [Abstract][Full Text] [Related]
48. Blood-brain barrier phenylalanine transport and individual vulnerability in phenylketonuria. Möller HE; Weglage J; Wiedermann D; Ullrich K J Cereb Blood Flow Metab; 1998 Nov; 18(11):1184-91. PubMed ID: 9809507 [TBL] [Abstract][Full Text] [Related]
49. In vivo NMR spectroscopy in patients with phenylketonuria: clinical significance of interindividual differences in brain phenylalanine concentrations. Weglage J; Möller HE; Wiedermann D; Cipcic-Schmidt S; Zschocke J; Ullrich K J Inherit Metab Dis; 1998 Feb; 21(1):81-2. PubMed ID: 9501277 [No Abstract] [Full Text] [Related]
50. Phenylalanine metabolism in the phenylpyruvic condition. I. Distribution, pool size, and turnover rate in human phenylketonuria. GRUMER HD; KOBLET H; WOODARD C J Clin Invest; 1961 Sep; 40(9):1758-65. PubMed ID: 13709234 [No Abstract] [Full Text] [Related]
51. [Functional exploration at various levels of the tryptophan--nicotinic acid metabolic line]. Chiancone FM Acta Vitaminol Enzymol; 1972; 26(3):81-92. PubMed ID: 4264240 [No Abstract] [Full Text] [Related]
53. Experimentally induced phenylketonuria. I. Inhibitors of phenylalanine hydroxylase. DeGraw JI; Cory M; Skinner WA; Theisen MC; Mitoma C J Med Chem; 1967 Jan; 10(1):64-6. PubMed ID: 6069058 [No Abstract] [Full Text] [Related]
54. [Niacin tests and their further development]. Imano J Nihon Saikingaku Zasshi; 1965 Jul; 20(7):326-45. PubMed ID: 5894897 [No Abstract] [Full Text] [Related]
55. Histological and chemical studies of a case of phenylketonuria with long survival. Forssman H; Kristensson K; Sourander P; Svennerholm L J Ment Defic Res; 1967 Sep; 11(3):194-206. PubMed ID: 6056807 [No Abstract] [Full Text] [Related]